Eintrag weiter verarbeiten
Insight into the complex regulation of CD133 in glioma
Gespeichert in:
| Zeitschriftentitel: | International Journal of Cancer |
|---|---|
| Personen und Körperschaften: | , |
| In: | International Journal of Cancer, 128, 2011, 3, S. 501-510 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Campos, Benito Herold‐Mende, Christel C. Campos, Benito Herold‐Mende, Christel C. |
|---|---|
| author |
Campos, Benito Herold‐Mende, Christel C. |
| spellingShingle |
Campos, Benito Herold‐Mende, Christel C. International Journal of Cancer Insight into the complex regulation of CD133 in glioma Cancer Research Oncology |
| author_sort |
campos, benito |
| spelling |
Campos, Benito Herold‐Mende, Christel C. 0020-7136 1097-0215 Wiley Cancer Research Oncology http://dx.doi.org/10.1002/ijc.25687 <jats:title>Abstract</jats:title><jats:p>The transmembrane protein CD133 and its extracellular epitope AC133 are controversial cancer markers. In glioma, AC133 demarcates a subpopulation of stem‐like tumor cells, so‐called cancer stem cells (CSCs), which seem to drive tumor formation and are highly resistant to conventional chemo‐ and radiotherapy. Lately, experimental evidence for the existence of AC133‐independent CSCs has challenged the importance previously attributed to AC133‐positive glioma cells. These findings either imply that (<jats:italic>i</jats:italic>) AC133‐positive and AC133‐negative glioma cells comprise different, independent CSC populations, (<jats:italic>ii</jats:italic>) AC133‐positive glioma cells are derived from primordial AC133‐negative CSCs or (<jats:italic>iii</jats:italic>) AC133‐negative CSCs have lost AC133 expression, while retaining their stem‐like features and tumor initiation capacity, and can reacquire AC133 expression <jats:italic>in vivo</jats:italic>. In our article, we review evidence for and against each of the possible tumor models in glioma and will discuss technical hurdles in the AC133 detection process. In addition, we will outline new insights into CD133 regulation, which suggest certain degree of plasticity between some AC133‐positive and AC133‐negative CSC populations.</jats:p> Insight into the complex regulation of CD133 in glioma International Journal of Cancer |
| doi_str_mv |
10.1002/ijc.25687 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9pamMuMjU2ODc |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9pamMuMjU2ODc |
| institution |
DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 |
| imprint |
Wiley, 2011 |
| imprint_str_mv |
Wiley, 2011 |
| issn |
0020-7136 1097-0215 |
| issn_str_mv |
0020-7136 1097-0215 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
campos2011insightintothecomplexregulationofcd133inglioma |
| publishDateSort |
2011 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
International Journal of Cancer |
| source_id |
49 |
| title |
Insight into the complex regulation of CD133 in glioma |
| title_unstemmed |
Insight into the complex regulation of CD133 in glioma |
| title_full |
Insight into the complex regulation of CD133 in glioma |
| title_fullStr |
Insight into the complex regulation of CD133 in glioma |
| title_full_unstemmed |
Insight into the complex regulation of CD133 in glioma |
| title_short |
Insight into the complex regulation of CD133 in glioma |
| title_sort |
insight into the complex regulation of cd133 in glioma |
| topic |
Cancer Research Oncology |
| url |
http://dx.doi.org/10.1002/ijc.25687 |
| publishDate |
2011 |
| physical |
501-510 |
| description |
<jats:title>Abstract</jats:title><jats:p>The transmembrane protein CD133 and its extracellular epitope AC133 are controversial cancer markers. In glioma, AC133 demarcates a subpopulation of stem‐like tumor cells, so‐called cancer stem cells (CSCs), which seem to drive tumor formation and are highly resistant to conventional chemo‐ and radiotherapy. Lately, experimental evidence for the existence of AC133‐independent CSCs has challenged the importance previously attributed to AC133‐positive glioma cells. These findings either imply that (<jats:italic>i</jats:italic>) AC133‐positive and AC133‐negative glioma cells comprise different, independent CSC populations, (<jats:italic>ii</jats:italic>) AC133‐positive glioma cells are derived from primordial AC133‐negative CSCs or (<jats:italic>iii</jats:italic>) AC133‐negative CSCs have lost AC133 expression, while retaining their stem‐like features and tumor initiation capacity, and can reacquire AC133 expression <jats:italic>in vivo</jats:italic>. In our article, we review evidence for and against each of the possible tumor models in glioma and will discuss technical hurdles in the AC133 detection process. In addition, we will outline new insights into CD133 regulation, which suggest certain degree of plasticity between some AC133‐positive and AC133‐negative CSC populations.</jats:p> |
| container_issue |
3 |
| container_start_page |
501 |
| container_title |
International Journal of Cancer |
| container_volume |
128 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792342995641565193 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T16:44:38.765Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Insight+into+the+complex+regulation+of+CD133+in+glioma&rft.date=2011-02-01&genre=article&issn=1097-0215&volume=128&issue=3&spage=501&epage=510&pages=501-510&jtitle=International+Journal+of+Cancer&atitle=Insight+into+the+complex+regulation+of+CD133+in+glioma&aulast=Herold%E2%80%90Mende&aufirst=Christel+C.&rft_id=info%3Adoi%2F10.1002%2Fijc.25687&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792342995641565193 |
| author | Campos, Benito, Herold‐Mende, Christel C. |
| author_facet | Campos, Benito, Herold‐Mende, Christel C., Campos, Benito, Herold‐Mende, Christel C. |
| author_sort | campos, benito |
| container_issue | 3 |
| container_start_page | 501 |
| container_title | International Journal of Cancer |
| container_volume | 128 |
| description | <jats:title>Abstract</jats:title><jats:p>The transmembrane protein CD133 and its extracellular epitope AC133 are controversial cancer markers. In glioma, AC133 demarcates a subpopulation of stem‐like tumor cells, so‐called cancer stem cells (CSCs), which seem to drive tumor formation and are highly resistant to conventional chemo‐ and radiotherapy. Lately, experimental evidence for the existence of AC133‐independent CSCs has challenged the importance previously attributed to AC133‐positive glioma cells. These findings either imply that (<jats:italic>i</jats:italic>) AC133‐positive and AC133‐negative glioma cells comprise different, independent CSC populations, (<jats:italic>ii</jats:italic>) AC133‐positive glioma cells are derived from primordial AC133‐negative CSCs or (<jats:italic>iii</jats:italic>) AC133‐negative CSCs have lost AC133 expression, while retaining their stem‐like features and tumor initiation capacity, and can reacquire AC133 expression <jats:italic>in vivo</jats:italic>. In our article, we review evidence for and against each of the possible tumor models in glioma and will discuss technical hurdles in the AC133 detection process. In addition, we will outline new insights into CD133 regulation, which suggest certain degree of plasticity between some AC133‐positive and AC133‐negative CSC populations.</jats:p> |
| doi_str_mv | 10.1002/ijc.25687 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9pamMuMjU2ODc |
| imprint | Wiley, 2011 |
| imprint_str_mv | Wiley, 2011 |
| institution | DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1 |
| issn | 0020-7136, 1097-0215 |
| issn_str_mv | 0020-7136, 1097-0215 |
| language | English |
| last_indexed | 2024-03-01T16:44:38.765Z |
| match_str | campos2011insightintothecomplexregulationofcd133inglioma |
| mega_collection | Wiley (CrossRef) |
| physical | 501-510 |
| publishDate | 2011 |
| publishDateSort | 2011 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | International Journal of Cancer |
| source_id | 49 |
| spelling | Campos, Benito Herold‐Mende, Christel C. 0020-7136 1097-0215 Wiley Cancer Research Oncology http://dx.doi.org/10.1002/ijc.25687 <jats:title>Abstract</jats:title><jats:p>The transmembrane protein CD133 and its extracellular epitope AC133 are controversial cancer markers. In glioma, AC133 demarcates a subpopulation of stem‐like tumor cells, so‐called cancer stem cells (CSCs), which seem to drive tumor formation and are highly resistant to conventional chemo‐ and radiotherapy. Lately, experimental evidence for the existence of AC133‐independent CSCs has challenged the importance previously attributed to AC133‐positive glioma cells. These findings either imply that (<jats:italic>i</jats:italic>) AC133‐positive and AC133‐negative glioma cells comprise different, independent CSC populations, (<jats:italic>ii</jats:italic>) AC133‐positive glioma cells are derived from primordial AC133‐negative CSCs or (<jats:italic>iii</jats:italic>) AC133‐negative CSCs have lost AC133 expression, while retaining their stem‐like features and tumor initiation capacity, and can reacquire AC133 expression <jats:italic>in vivo</jats:italic>. In our article, we review evidence for and against each of the possible tumor models in glioma and will discuss technical hurdles in the AC133 detection process. In addition, we will outline new insights into CD133 regulation, which suggest certain degree of plasticity between some AC133‐positive and AC133‐negative CSC populations.</jats:p> Insight into the complex regulation of CD133 in glioma International Journal of Cancer |
| spellingShingle | Campos, Benito, Herold‐Mende, Christel C., International Journal of Cancer, Insight into the complex regulation of CD133 in glioma, Cancer Research, Oncology |
| title | Insight into the complex regulation of CD133 in glioma |
| title_full | Insight into the complex regulation of CD133 in glioma |
| title_fullStr | Insight into the complex regulation of CD133 in glioma |
| title_full_unstemmed | Insight into the complex regulation of CD133 in glioma |
| title_short | Insight into the complex regulation of CD133 in glioma |
| title_sort | insight into the complex regulation of cd133 in glioma |
| title_unstemmed | Insight into the complex regulation of CD133 in glioma |
| topic | Cancer Research, Oncology |
| url | http://dx.doi.org/10.1002/ijc.25687 |